These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8765893)

  • 1. [Hyperhomocyst(e)inemia--an independent risk factor of stroke].
    Lalouschek W; Aull S; Deecke L; Schnider P; Uhl F; Zeiler K
    Fortschr Neurol Psychiatr; 1996 Jul; 64(7):271-7. PubMed ID: 8765893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
    Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes and consequences of hyperhomocyst(e)inemia.
    Pietrzik K; Brönstrup A
    Int J Vitam Nutr Res; 1997; 67(5):389-95. PubMed ID: 9350483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
    Moghadasian MH; McManus BM; Frohlich JJ
    Arch Intern Med; 1997 Nov; 157(20):2299-308. PubMed ID: 9361570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocyst(e)inemia--determining factors and treatment.
    Genest J
    Can J Cardiol; 1999 Apr; 15 Suppl B():35B-38B. PubMed ID: 10350684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.
    Henning BF; Zidek W; Riezler R; Graefe U; Tepel M
    Res Exp Med (Berl); 2001 Mar; 200(3):155-68. PubMed ID: 11426667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension?
    Virdis A; Ghiadoni L; Salvetti G; Versari D; Taddei S; Salvett A
    J Nephrol; 2002; 15(4):414-21. PubMed ID: 12243373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocyst(e)inemia, related vitamins and dementias.
    Delport R
    J Nutr Health Aging; 2000; 4(4):195-6. PubMed ID: 11115799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
    Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM
    Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease.
    Kang SS; Wong PW; Malinow MR
    Annu Rev Nutr; 1992; 12():279-98. PubMed ID: 1503807
    [No Abstract]   [Full Text] [Related]  

  • 12. Homocyst(e)ine, vitamins and genetic interactions in vascular disease.
    Malinow MR
    Can J Cardiol; 1999 Apr; 15 Suppl B():31B-34B. PubMed ID: 10350683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
    Lentz SR; Malinow MR; Piegors DJ; Bhopatkar-Teredesai M; Faraci FM; Heistad DD
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.
    Kang SS; Wong PW
    Atherosclerosis; 1996 Jan; 119(2):135-8. PubMed ID: 8808490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
    Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P
    Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of heterozygotes for recessive alleles. Homocyst(e)inemia: paradigm of pitfalls in phenotypes.
    McGill JJ; Mettler G; Rosenblatt DS; Scriver CR
    Am J Med Genet; 1990 May; 36(1):45-52. PubMed ID: 2185635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oxidant stress of hyperhomocyst(e)inemia.
    Loscalzo J
    J Clin Invest; 1996 Jul; 98(1):5-7. PubMed ID: 8690803
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperhomocysteinemia: atherothrombosis and neurotoxicity].
    Fridman O
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(1):21-30. PubMed ID: 10797837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
    Langman LJ; Ray JG; Evrovski J; Yeo E; Cole DE
    Arch Intern Med; 2000 Apr; 160(7):961-4. PubMed ID: 10761961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of folic acid, pyridoxal phosphate and cobalamin on plasma homocyst(e)ine levels and the susceptibility of low-density lipoprotein to ex-vivo oxidation.
    Weiss N; Feussner A; Hailer S; Spengel FA; Keller C; Wolfram G
    Eur J Med Res; 1999 Oct; 4(10):425-32. PubMed ID: 10527956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.